Malaysia’s IHH Hits Roadblock in Buying Indian Hospital Group Fortis
Japanese drugmaker Daiichi Sankyo's court filing could delay deal.
IHH Healthcare’s planned purchase of Indian hospital group Fortis Healthcare could be derailed depending on how a local court rules in response to Japanese drugmaker Daiichi Sankyo’s protest.
Malaysia-based IHH said last month it will acquire Fortis for up to $1.1 billion. The plan is to acquire a majority stake through a combination of private placement and tender offer by the end of 2018.